We are live on ! Find out more
VERA icon

Vera Therapeutics
VERA

22 hedge funds and large institutions have $186M invested in Vera Therapeutics in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

69.21% more ownership

Funds ownership: 0% → 69.21% (+69%)

Holders
22
Holders Change
+22
Holders Change %
–
% of All Funds
0.38%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.07%
New
22
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$48.5M
2
A
Abingworth
United Kingdom
+$46M
3
SI
Sofinnova Investments
California
+$45.3M
4
Citadel Advisors
Citadel Advisors
Florida
+$27M
5
KXA
KPCB XVI Associates
California
+$20.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SI
1
Sofinnova Investments
California
$38.6M +$45.3M +2,914,776 New
A
2
Abingworth
United Kingdom
$38.5M +$46M +2,960,231 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$38.5M +$48.5M +3,122,512 New
Citadel Advisors
4
Citadel Advisors
Florida
$22.2M +$27M +1,738,693 New
KXA
5
KPCB XVI Associates
California
$16M +$20.9M +1,343,152 New
OCA
6
Octagon Capital Advisors
New York
$15M +$17.6M +1,132,671 New
AI
7
Alphabet Inc
California
$12.5M +$14.7M +944,791 New
Millennium Management
8
Millennium Management
New York
$1.08M +$1.27M +81,452 New
PHP
9
Parkman Healthcare Partners
Connecticut
$1M +$1.18M +75,638 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$693K +$812K +52,268 New
MIM
11
Monashee Investment Management
Massachusetts
$611K +$716K +46,069 New
CCM
12
CAAS Capital Management
New York
$265K +$311K +20,000 New
RJFSA
13
Raymond James Financial Services Advisors
Florida
$236K +$277K +17,828 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$213K +$250K +16,076 New
MS
15
Maven Securities
Jersey
$178K +$202K +13,000 New
ECM
16
ExodusPoint Capital Management
New York
$170K +$200K +12,841 New
Goldman Sachs
17
Goldman Sachs
New York
$156K +$183K +11,747 New
Bank of America
18
Bank of America
North Carolina
$82K +$96.5K +6,212 New
Morgan Stanley
19
Morgan Stanley
New York
$24K +$27.7K +1,784 New
UBS Group
20
UBS Group
Switzerland
$13K +$14.9K +956 New
BlackRock
21
BlackRock
New York
$8K +$9.21K +593 New
Wells Fargo
22
Wells Fargo
California
– +$435 +28 New

VERA Hedge Fund Activity: Q2 2021 in Review

22 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Vera Therapeutics (VERA) for Q2 2021, worth a combined $186M.

Buyers outnumbered sellers: 22 funds opened new VERA positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $48.5M.

  • 22 institutional investors held Vera Therapeutics (VERA) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $186M of Vera Therapeutics stock for Q2 2021.
  • 22 funds opened new Vera Therapeutics positions in Q2 2021 and 0 closed out, a net change of +22 holders.
  • The largest Vera Therapeutics buyer in Q2 2021 was Fidelity Investments, an estimated $48.5M added.

Based on aggregated 13F filings for Q2 2021.